News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Ainhoa Madariaga: Rethinking control arms in platinum-resistant/refractory ovarian cancer
Ainhoa Madariaga/comunidad.madrid
Feb 8, 2025, 19:15

Ainhoa Madariaga: Rethinking control arms in platinum-resistant/refractory ovarian cancer

Ainhoa Madariaga, Medical Oncologist at University Hospital October 12, shared an article by Husam A. Alqaisi, et al. on X:

“Rethinking control arms in PlatR ovarian cancer.

Investigator initiated Phase II trial:

Anetumab+Bev vs weekly Taxol +Bev.

Weekly Taxol+ Bev: mPFS 12.7m, ORR 65%.

Role of IL6?”

Randomized phase II study of bevacizumab with weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant/refractory high grade ovarian cancer (NCI trial).

Authors: Husam A. Alqaisi, et al.

Ainhoa Madariaga: Rethinking control arms in platinum-resistant/refractory ovarian cancer

12 Octubre University Hospital Ainhoa Madariaga Anetumab anetumab ravtansine Bevacizumab cancer fight against cancer Global fight against cancer Husam A. Alqaisi MedOnc OncoDaily Oncology Ovarian Cancer Paclitaxel
Special Coverage
Insight
Apr 15, 2025, 12:48
Yvonne Bombard presented on Mitigating Disparities in Hereditary Cancer Genetics at 2025 OMPRN Webinar
Blog
Apr 15, 2025, 12:44
CancerWorld Cover Conversations - A chance to connect with the giants in the field of oncology
Blog
Apr 15, 2025, 12:42
Fumiko Ladd Chino: Projected Lifetime Cancer Risks From Current Computed Tomography Imaging
Blog
Apr 15, 2025, 12:34
Chandler Park: Great privilege to advocate for cancer patients at the 2025 ASCO Advocacy Summit
Societies
Apr 15, 2025, 12:34
American Cancer Society Cancer Action Network launched 2025 annual Giving Week
Blog
Apr 15, 2025, 12:29
Wafaa M Rashed: Mutaz Mohamed on the urgent need to expand affordable genetic testing across African nations
Blog
Apr 15, 2025, 12:23
Conquer Cancer - Julie Gralow discusses how aspiring grant makers can utilize grant management services
Societies
Apr 15, 2025, 12:21
The Pediatric Oncology East and Mediterranean Group's (POEM) 4th Scientific Meeting
Blog
Apr 15, 2025, 12:18
Erick Mahatara: Almost 75% deaths in the world are due to NCDs, and the urgency around these diseases still seems too low
Blog
Apr 15, 2025, 12:17
Bernard A. Fox: Great commentary from Nature Medicine on vaccine hesitancy and the threat presented by the new leadership of HHS
Blog
Apr 15, 2025, 12:17
Duke Radiation Oncology - Olivia Franek presenting radiation oncology patient education videos project at ONS Congress
Blog
Apr 15, 2025, 12:08
Luis Lara-Mejía: Oncogenic fusions represent a diagnostic challenge across solid tumors